RedHotStocks

RedHotStocks

Today may just be a wobble in the market or the start of a much greater fall coming. Complacency has set in and a 12% move in the VIX today was a warning shoot to us all. It would be very wise to accumulate at the current levels because a 20-30% spike will give a great hedge against a sudden drop in the market.

RedHotStocks

May not be a name that many investors are familiar with but since its IPO, it has suffered the same issues as most, quick spike and very quick drop, losing investor confidence and seen as trading equity only. Investors are starting to take notice due to its outstanding growth and 140% return for investors in 1 year. Although at its current levels, it is at a very...

RedHotStocks

The last few earnings reports from ATVI have been disasters not purely on the results but also on the delivery, hopefully that improves. The stock has built a very strong support base, so we are quite confident that some positive price action could follow tomorrows report. Unfortunately the timing is not great for ATVI as the market has taken a speed wobble today,...

RedHotStocks

Regardless of the long term price action, BCH is setting up nicely for a short term bullish break from a bull flag formation.

RedHotStocks Updated 

Despite FDA approval for Amgen's new Enrel drug last week we see the bounce as the formation of a bear flag heading into earnings. Sentiment is so poor in the sector we fear that regardless of results the stock will eventually continue to drop. Amgen is very cheap at 14 P/E ratio with an average rating of HOLD among 25 analysts covering the name. Amgen, Inc. is...

RedHotStocks

From a charting perspective Teva is approaching a key level, its make or break and earnings will be the catalysts for that move. Teva is still carrying the cross for overpaying for its acquisitions, although revenue is expected to rise earnings are expected to drop. Vanguard Health Care Fund added to a holding in Teva Pharmaceutical Industries Ltd by 65.14%. The...

RedHotStocks

Having easily outperformed Tencent and Netease, confidence is high going into earnings. The stock price is ready to make a breakout above resistance from 2014 , fueled by increased revenue partly from hit game ‘Empires & Puzzles’ which could be over 30% of total revenue. It is a risky stock given the high P/E ratio but we will see if growth can catch up with the...

RedHotStocks

Investors in XPO needed a great deal of loyalty to stick with them through the 65% decline from Sept -DEC 2018. There is and was multiple factors working against the logistics company, worldwide trade disruption, Brexit and the strong Dollar have reduced revenue and profit margins. Its difficult to see how any of those factors have changed over the last 6 months...

RedHotStocks

It seems that the explosive move in MCD may have come to a end, after a initial pop on earnings, selling ensued quickly as investors banked sizable profits gained. We would assume that the stock was used as a quick trade lately rather than a investment given the sharp loss in momentum. Strong support exists at $190 and a possible back-test would be a positive long...

RedHotStocks

Paycom is a under the radar stock which has rewarded investors handsomely, having already had a 23% move since the last earnings report, it may be difficult to reciprocate that. This morning 5 analysts have increased their price targets which may bring extra interest into the stock. Company Description Paycom Software, Inc. provides comprehensive, cloud-based...

RedHotStocks

Square has really struggled to find any momentum in a very strong market which is not a great sign approaching earnings. The bearish scenario is that SQ is still in correction from the overbought condition from Sept 18, investors have moved on as we can see from the volume profile which is steadily decreasing. The Chaikin Money Flow is in decline, as is the RSI....

RedHotStocks

Only 2 years ago Trivago was $24 per share and is now trading in the $5 range which i'm sure was unthinkable for investors back then. It is practically a certainty that revenue will take a major drop but solace may be taken from the fact earnings may not be as poor as analysts estimate. Given the fact sentiment is so negative, any good news could pop the stock...

RedHotStocks

Estee reports tomorrow morning and is likely to beat easily, but it is also likely that some profit taking will ensue, which could provide a very good entry level for a stock we previously missed out on. Company Description The Estée Lauder Companies, Inc. engages in the manufacture of skin care, makeup, fragrance and hair care products. It sells products...

RedHotStocks

Strong hints of a great earnings report for AKAM , in the sweet spot of many sectors, growth has and will continue to be amazing. The stock is currently breaking out prior to earnings and with customers such as Microsoft , a bright future is ahead. Company Description Akamai Technologies, Inc. engages in the provision of cloud services for delivering, optimizing...

RedHotStocks

The monthly close today is a key moment for they Crypto Markets for months to come. On the last occasion the 12ema was challenged in November, we had an explosive sell off. We expect quite a battle at the daily close and will be nimble, preferably the price remains bullish.

RedHotStocks

We are looking for a break of resistance in GS at $209 for a quick jump to $219, price action is limited in this zone given the speed in which the stock dropped. We hope for a speedy move up to the golden pocket at approx $228. If and when the wheels fall of tech , financials is where the wise money will continue to hide out. We are bullish financials.

RedHotStocks

Highly speculative but has engaged our interest with volume and price spikes over the course of the last week. Up again today premarket and rumor mill is very active as is the case with many Bio-Pharm space.On the watchlist for breakout. Company Description vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and...

RedHotStocks

Sentiment in the Pharma sector is terrible at the moment, with no sign of changing until possibly after the 2020 elections. Healthcare is a hot topic on the minds off all candidates running for election with differing views on policy and pricing. so we see it as a no go zone. Pfizers chart is very negative with indicators all turned lower and a death cross on the...